Recombinant chimeric antigen ChimLyme for Borrelia burgdorferi
ChimLyme is a chimeric multiantigen for Lyme Disease produced by Borrelia burgdorferi sensu stricto.
Disease caused mainly to dogs, horses and occasionally in beef cattle.
Name
ChimLyme
Description
Recombinant chimeric antigen for Borrelia burgdorferi
Purity
> 95% by observation on SDS-PAGE electrophoresis
Cat number
| SKU | Source | Applications | In-house validation | Details |
|---|---|---|---|---|
| RAG0027 (B. burgdorferi, chimera) | E. coli | WB, DB, IE, DE, CLIA, LF | ELISA |
|
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg, 1 mg and bulk
Related products
Also avaliable for diagnosis of Lyme borreliosis (or Lyme disease) in humans
For research and comercial use IVD only (*)
(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.
Bact to list of Proteins for animal infectious diseases
